快速多参数定量MRI预测甲状腺相关眼病活动性:结合临床特征
前瞻性纳入136例甲状腺相关眼病(TAO)患者(活动期72例、非活动期64例)及30名健康对照,采用合成MRI(syMRI)定量眼外肌、眶脂肪和泪腺参数。活动期TAO患者T1弛豫时间(T1RT)、T2弛豫时间(T2RT)及单核细胞显著高于非活动期,高密度脂蛋白(HDL)显著低于非活动期。T1RT、T2RT和HDL为TAO活动性的独立预测因子;HDL联合T1RT、T2RT预测活动期TAO的AUC为0.884,敏感度80.56%、特异度85.71%、准确率82.35%。
要点
- 活动期TAO患者眼外肌T1RT、T2RT显著高于非活动期患者(p<0.05)。
- T1RT(OR 1.003)、T2RT(OR 1.102)和HDL(OR 0.222)为TAO活动性的独立预测因子。
- HDL联合T1RT、T2RT预测活动期TAO的AUC为0.884,高于T1RT联合T2RT(AUC 0.872)。
核心结论
- 基于syMRI的T1RT和T2RT可辅助预测TAO活动性,将syMRI影像参数与临床特征(HDL)整合可进一步提升预测性能。
研究设计与样本
- 前瞻性研究,纳入136例TAO患者(活动期72例、非活动期64例)和30名健康对照,由两名放射科医师勾画眼外肌、眶脂肪和泪腺,比较组间临床特征与影像参数,采用逻辑回归分析独立危险因素并建立预测模型。
关键影像表现/征象
- 活动期TAO患者T1RT、T2RT和单核细胞显著高于非活动期患者(p<0.05)。
- 活动期TAO患者HDL显著低于非活动期患者(p<0.05)。
诊断标准与关键数值
- T1RT预测活动期TAO的AUC为0.804。
- T2RT预测活动期TAO的AUC为0.800。
- HDL预测活动期TAO的AUC为0.636。
- T1RT联合T2RT预测活动期TAO的AUC为0.872。
- HDL联合T1RT、T2RT预测活动期TAO的AUC为0.884,敏感度80.56%、特异度85.71%、准确率82.35%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To explore the feasibility of synthetic MRI (syMRI), one kind of rapid multiparametric quantitative MRI, and assess the predictive value of combining the syMRI parameters with clinical features for predicting the activity of thyroid-associated ophthalmopathy (TAO).
MATERIALS AND METHODS: Clinical data and syMRI images were prospectively collected from 136 patients with TAO (72 active and 64 inactive) and 30 healthy controls. Two radiologists outlined the extraocular muscles (EOMs), orbital fat, and lacrimal glands. The clinical features and imaging parameters were compared between groups. Logistic regression analysis was used to evaluate independent risk factors of active TAO patients and establish a predictive model.
RESULTS: Active TAO patients had significantly higher T1 relaxation time (T1RT), T2 relaxation time (T2RT), and monocyte (MONO), but significantly lower high-density lipoprotein (HDL) than inactive TAO patients (p < 0.05). Multivariate logistic regression analysis identified T1RT (OR: 1.003, p < 0.001), T2RT (OR: 1.102, p < 0.001) and HDL (OR: 0.222, p = 0.025) as independent predictors of TAO activity. Combining HDL with the T1RT and T2RT from syMRI yielded the best performance in predicting patients with active TAO (AUC: 0.884), with the sensitivity, specificity, and accuracy of 80.56%, 85.71%, and 82.35%. Second, the combination of T1RT and T2RT achieved predictive performance (AUC: 0.872), followed by T1RT (AUC: 0.804) and T2RT (AUC: 0.800), and lastly HDL (AUC: 0.636).
CONCLUSIONS: The T1RT and T2RT based on syMRI can assist in predicting TAO activity. The integration of imaging parameters from syMRI with clinical features further enhances predictive performance.
KEY POINTS: Question The therapy for thyroid-associated ophthalmopathy (TAO) is activity-dependent. Nevertheless, clinical evaluation has shortcomings, and synthetic MRI (syMRI) can provide a quantitative foundation for assessing it. Findings T1 relaxation time (T1RT) and T2 relaxation time (T2RT) based on syMRI can effectively predict TAO activity, and the combination of them improves prediction performance. Clinical relevance The combination of T1RT and T2RT based on syMRI with clinical indicators can comprehensively assess the activity of TAO, thereby facilitating accurate and timely selection of treatments in clinical practice.
引用
- Wang Y, Cui Y, Cheng Y, et al. Rapid multiparametric quantitative MRI for predicting the activity of thyroid-associated ophthalmopathy: combination with clinical characteristics. Eur Radiol. 2025. PMID: 40488887. doi:10.1007/s00330-025-11691-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。